{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:14:26Z","timestamp":1790709266845,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFE0101800"],"award-info":[{"award-number":["2018YFE0101800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1200105"],"award-info":[{"award-number":["2018YFC1200105"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The objective of the study was to investigate the antimicrobial susceptibility and extended-spectrum beta-lactamase (ESBL) positive rates of <jats:italic>Escherichia coli<\/jats:italic> from community-acquired urinary tract infections (CA-UTIs) in Chinese hospitals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>A total of 809 <jats:italic>E. coli<\/jats:italic> isolates from CA-UTIs in 10 hospitals (5 tertiary and 5 secondary hospitals) from different regions in China were collected during the period 2016\u20132017 according to the strict inclusion criteria. Antimicrobial susceptibility testing was carried out by standard broth microdilution method. Isolates were categorized as ESBL-positive, ESBL-negative, and ESBL-uncertain groups according to the CLSI recommended phenotypic screening method. ESBL and AmpC genes were amplified and sequenced on ESBL-positive and ESBL-uncertain isolates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The antimicrobial agents with susceptibility rates of greater than 95% included imipenem (99.9%), colistin (99.6%), ertapenem (98.9%), amikacin (98.3%), cefmetazole (97.9%), nitrofurantoin (96%), and fosfomycin (95.4%). However, susceptibilities to cephalosporins (varying from 58.6% to 74.9%) and levofloxacin (48.8%) were relatively low. In the phenotypic detection of ESBLs, ESBL-positive isolates made up 38.07% of <jats:italic>E. coli<\/jats:italic> strains isolated from CA-UTIs, while 2.97% were ESBL-uncertain. Antimicrobial susceptibilities of imipenem, cefmetazole, colistin, ertapenem, amikacin, and nitrofurantoin against ESBL-producing <jats:italic>E. coli<\/jats:italic> strains were greater than 90%. The percentage of ESBL-producing strains was higher in male (53.6%) than in female patients (35.2%) (<jats:italic>p<\/jats:italic> &amp;lt; <jats:italic>0.001<\/jats:italic>). CTX-M-14 (31.8%) was the major CTX-M variant in the ESBL-producing <jats:italic>E. coli<\/jats:italic>, followed by CTX-M-55 (23.4%), CTX-M-15 (17.5%), and CTX-M-27 (13.3%). The prevalence of carbapenem-resistant <jats:italic>E. coli<\/jats:italic> among CA-UTI isolates was 0.25% (2\/809).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study indicated high prevalence of ESBL in <jats:italic>E. coli<\/jats:italic> strains from strictly defined community-acquired urinary tract infections in adults in China. Imipenem, colistin, ertapenem, amikacin, and nitrofurantoin were the most active antimicrobials against ESBL-positive <jats:italic>E. coli<\/jats:italic> isolates. <jats:italic>bla<\/jats:italic><jats:sub><jats:italic>CTX\u2013M\u2013<\/jats:italic><\/jats:sub><jats:sub>14<\/jats:sub> is the predominant <jats:italic>esbl<\/jats:italic> gene in ESBL-producing and ESBL-uncertain strains. Our study indicated that the use of cephalosporins and fluoroquinolone needs to be restricted for empirical treatment of CA-UTIs in China.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2021.663033","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T06:13:38Z","timestamp":1625638418000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["High Prevalence of Extended-Spectrum Beta-Lactamases in Escherichia coli Strains Collected From Strictly Defined Community-Acquired Urinary Tract Infections in Adults in China: A Multicenter Prospective Clinical Microbiological and Molecular Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Peiyao","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Kudinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1093\/jac\/dkv188","article-title":"Antibiotic-resistant ST38, ST131 and ST405 strains are the leading uropathogenic Escherichia coli clones in Riyadh, Saudi Arabia.","volume":"70","author":"Alghoribi","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.eimc.2016.02.018","article-title":"Evolution of antibiotic multiresistance in Escherichia coli and Klebsiella pneumoniae isolates from urinary tract infections: a 12-year analysis (2003-2014).","volume":"35","author":"Arana","year":"2017","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1128\/aac.47.3.1165-1168.2003","article-title":"Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 beta-lactamase production.","volume":"47","author":"Armand-Lef\u00e8vre","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/00325481.2017.1246055","article-title":"An update on the management of urinary tract infections in the era of antimicrobial resistance.","volume":"129","author":"Bader","year":"2017","journal-title":"Postgrad. Med."},{"key":"B5","article-title":"EAU Guidelines on Urological Infections 2020 [Online].","author":"Bonkat","year":"2020"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1128\/jcm.02503-10","article-title":"Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals.","volume":"49","author":"Cao","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/apm.12260","article-title":"Genotypic characteristics of multidrug-resistant Escherichia coli isolates associated with urinary tract infections.","volume":"122","author":"Cao","year":"2014","journal-title":"APMIS"},{"key":"B8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.medmal.2017.09.013","article-title":"Antimicrobial resistance in community-acquired urinary tract infections in Paris in 2015.","volume":"48","author":"Chervet","year":"2018","journal-title":"Med. Mal. Infect."},{"key":"B9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/iju.13493","article-title":"Summary of the UAA-AAUS guidelines for urinary tract infections.","volume":"25","author":"Choe","year":"2018","journal-title":"Int. J. Urol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.meegid.2018.04.005","article-title":"Current epidemiology, genetic evolution and clinical impact of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae.","volume":"61","author":"Chong","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"B11","year":"2020","journal-title":"Performance Standards for Antimicrobial Susceptibility Testing, Document M100"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03559.x","article-title":"Antibiotic susceptibility of Escherichia coli strains causing community-acquired urinary tract infection.","volume":"17","author":"Esp\u00ednola","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"B13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1574-6968.2000.tb09283.x","article-title":"Treatment options for extended-spectrum beta-lactamase-producers.","volume":"190","author":"Essack","year":"2000","journal-title":"FEMS Microbiol. Lett."},{"key":"B14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.16718\/j.1009-7708.2017.05.001","article-title":"CHINET surveillance of bacterial resistance across China: report of the results in 2016.","volume":"17","author":"Fupin","year":"2017","journal-title":"Chin. J. Infect. Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4067\/s0716-10182018000100029","article-title":"Molecular characterization and antimicrobial susceptibility pattern of extended-spectrum \u03b2-lactamase-producing Escherichia coli as cause of community acquired urinary tract infection.","volume":"35","author":"Galindo-M\u00e9ndez","year":"2018","journal-title":"Rev. Chilena Infectol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijantimicag.2005.09.013","article-title":"Transferable DHA-1 cephalosporinase in Escherichia coli.","volume":"27","author":"Giakkoupi","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jiac.2019.02.021","article-title":"Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016: antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus.","volume":"25","author":"Hayami","year":"2019","journal-title":"J. Infect. Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: quinolone resistance.","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01611","article-title":"Antimicrobial susceptibility and virulence of mcr-1-positive Enterobacteriaceae in China, a multicenter longitudinal epidemiological study.","volume":"11","author":"Jiang","year":"2020","journal-title":"Front. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3947\/ic.2014.46.4.226","article-title":"Clinical importance and epidemiology of quinolone resistance.","volume":"46","author":"Kim","year":"2014","journal-title":"Infect. Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/jac\/dkw574","article-title":"Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.","volume":"72","author":"Koksal","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.33073\/pjm-2019-048","article-title":"Antibiotic resistance among uropathogenic Escherichia coli.","volume":"68","author":"Kot","year":"2019","journal-title":"Pol. J. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jfma.2012.09.021","article-title":"Prevalence of carbapenemase-producing Enterobacteriaceae and its impact on clinical outcomes at a teaching hospital in Taiwan.","volume":"112","author":"Lai","year":"2013","journal-title":"J. Formos. Med. Assoc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/jac\/dkaa514","article-title":"Local characteristics associated with higher prevalence of ESBL-producing Escherichia coli in community-acquired urinary tract infections: an observational, cross-sectional study.","volume":"76","author":"Larramendy","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/med.20210","article-title":"New definitions of extended-spectrum \u03b2-lactamase conferring worldwide emerging antibiotic resistance.","volume":"32","author":"Lee","year":"2012","journal-title":"Med. Res. Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/jac\/dkl115","article-title":"Klebsiella pneumoniae strains carrying the chromosomal SHV-11 beta-lactamase gene produce the plasmid-mediated SHV-12 extended-spectrum beta-lactamase more frequently than those carrying the chromosomal SHV-1 beta-lactamase gene.","volume":"57","author":"Lee","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1128\/aac.45.10.2831-2837.2001","article-title":"Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.","volume":"45","author":"Livermore","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1128\/aac.05186-14","article-title":"Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013.","volume":"59","author":"Lob","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2016.04.022","article-title":"Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010-2014.","volume":"85","author":"Lob","year":"2016","journal-title":"Diagn Microbiol. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.2147\/idr.S256131","article-title":"Treatment failure in urinary tract infections: a warning witness for virulent multi-drug resistant ESBL- producing Escherichia coli.","volume":"13","author":"Naziri","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"B31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.diagmicrobio.2016.07.010","article-title":"Prevalence and quinolone resistance of fecal carriage of extended-spectrum \u03b2-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China.","volume":"86","author":"Ni","year":"2016","journal-title":"Diagn Microbiol. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3947\/ic.2017.49.3.184","article-title":"Antimicrobial susceptibilities of Enterobacteriaceae in community-acquired urinary tract infections during a 5-year period: a single hospital study in Korea.","volume":"49","author":"Park","year":"2017","journal-title":"Infect. Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1046\/j.1469-0691.2000.00107.x","article-title":"Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).","volume":"6","author":"Paterson","year":"2000","journal-title":"Clin. Microbiol. Infect."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004152","article-title":"Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study.","volume":"3","author":"Qiao","year":"2013","journal-title":"BMJ Open"},{"key":"B35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/jac\/49.3.557","article-title":"The ACT-1 plasmid-encoded AmpC beta-lactamase is inducible: detection in a complex beta-lactamase background.","volume":"49","author":"Reisbig","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/23744235.2020.1763452","article-title":"Incidence of community-onset extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae infections: an 11-year population-based study in Denmark.","volume":"52","author":"Richelsen","year":"2020","journal-title":"Infect. Dis. (Lond.)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/1469-0691.12646","article-title":"Pandemic lineages of extraintestinal pathogenic Escherichia coli.","volume":"20","author":"Riley","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ijantimicag.2014.11.015","article-title":"Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.","volume":"45","author":"Rogers","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151897","article-title":"Clinical significance of community- and healthcare-acquired carbapenem-resistant Enterobacteriaceae isolates.","volume":"11","author":"Tang","year":"2016","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/677157","article-title":"Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States.","volume":"35","author":"Thaden","year":"2014","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s10096-019-03655-3","article-title":"Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period.","volume":"38","author":"van Driel","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01834-17","article-title":"Persistent pandemic lineages of uropathogenic Escherichia coli in a college community from 1999 to 2017.","volume":"56","author":"Yamaji","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ijantimicag.2014.11.012","article-title":"In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum \u03b2-lactamases in China.","volume":"45","author":"Yang","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2296-x","article-title":"Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014.","volume":"17","author":"Yang","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5152\/tud.2016.90836","article-title":"Antimicrobial susceptibilities of Escherichia coli isolates as agents of community-acquired urinary tract infection (2008-2014).","volume":"42","author":"Y\u0131lmaz","year":"2016","journal-title":"Turk J. Urol."},{"key":"B46","first-page":"260","article-title":"Antimicrobial susceptibility surveillance of gram-negative bacterial from Mohnarin 2011-20112.","volume":"30","author":"Yun","year":"2014","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2147\/idr.S203572","article-title":"Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016-2017 update of the Chinese SMART study.","volume":"12","author":"Zhang","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"B48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/1040841x.2012.691460","article-title":"Epidemiology and genetics of CTX-M extended-spectrum \u03b2-lactamases in Gram-negative bacteria.","volume":"39","author":"Zhao","year":"2013","journal-title":"Crit. Rev. Microbiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.663033\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T06:13:41Z","timestamp":1625638421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.663033\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":48,"alternative-id":["10.3389\/fmicb.2021.663033"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.663033","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]},"article-number":"663033"}}